UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 14, 2008
VAXGEN, INC.
(Exact name of Registrant as Specified in its Charter)
| | | | | |
DELAWARE
(State or other jurisdiction
of organization) | | 0-26483
Commission
File Number) | | 94-3236309
(I.R.S. Employer incorporation
or Identification Number) |
349 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CALIFORNIA 94080
(Address of Principal Executive Offices)
Registrant’s Telephone Number, Including Area Code: (650) 624-1000
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| | |
| þ | | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| | |
| o | | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| | |
| o | | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| | |
| o | | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
TABLE OF CONTENTS
SECTION 1—REGISTRANT’S BUSINESS AND OPERATIONS
On March 14, 2008, VaxGen, Inc., or VaxGen, issued a press release announcing that its stock is now quoted on the OTC Bulletin Board under the symbol “VXGN.BB.” This press release is attached as Exhibit 99.1 to this report and is incorporated herein by reference.
| | |
| Item 9.01. | | Financial Statements and Exhibits. |
| | | |
| Exhibit | | |
| Number | | Description |
| |
| 99.1 | | Press release, dated March 14, 2008, entitled “VaxGen Common Stock Now Quoted on OTC Bulletin Board.” |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | | | |
| | | | | VaxGen, Inc. | | |
| | | | | (Registrant) | | |
| | | | | | | |
| Dated: March 17, 2008 | | By: | | /s/ Matthew J. Pfeffer | | |
| | | | | Matthew J. Pfeffer | | |
| | | | | Senior Vice President, Finance and | | |
| | | | | Administration and Chief Financial Officer | | |
EXHIBIT INDEX
| | | |
| Exhibit | | |
| Number | | Description |
| |
| 99.1 | | Press release, dated March 14, 2008, entitled “VaxGen Common Stock Now Quoted on OTC Bulletin Board.” |
